title: Induction of carcinomas and sarcomas by 9,10-dimethyl-1,2-benzanthracene administration into the hamster maxillary sinus.
abstract: To determine whether the local administration of 9,10-dimethyl-1,2-benzanthracene (DMBA) into the hamster maxillary sinus induced carcinoma at the injected site, hamsters were injected with 30 microliters of 0.5% solution of DMBA in dimethyl sulfoxide (DMSO) through the infraorbital foramen into the maxillary sinus once weekly for 10 weeks (Group 2). Another group of hamsters (Group 1) received similar injections of 30 microliters of DMSO only. In a third group of animals (Group 3), a roll of oxycellulose was inserted into the maxillary sinus and 40 microliters of a 2% solution of DMBA in DMSO was injected once. Sinonasal carcinomas were demonstrated in 73% (8/11) of the hamsters in Group 2 and sarcomas were shown in 73% (8/11) of the hamsters in Group 3, as well as some carcinomas. No tumors were seen in the Group 1 hamsters. Histologic examination revealed squamous cell carcinomas arising from the surface epithelium and submucous glands of the nasal cavity and maxillary sinus. These findings indicate that the intrasinal administration of a 0.5% solution of DMBA in DMSO is a reliable method for inducing maxillary sinus cancer.
authors.affiliation: Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Yura
authors.forename: H
authors.initials: H
authors.lastname: Tsujimoto
authors.forename: J
authors.initials: J
authors.lastname: Kusaka
authors.forename: K
authors.initials: K
authors.lastname: Harada
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Sato
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000008:administration & dosage / Q000009:adverse effects*; D000230:Adenocarcinoma / Q000139:chemically induced / Q000473:pathology; D000818:Animals; D002277:Carcinoma / Q000139:chemically induced* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000473:pathology; D002483:Cellulose, Oxidized; D006224:Cricetinae; D004121:Dimethyl Sulfoxide; D004195:Disease Models, Animal; D005354:Fibrosarcoma / Q000139:chemically induced / Q000473:pathology; D007267:Injections; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008647:Mesocricetus; D009296:Nasal Cavity / Q000187:drug effects / Q000473:pathology; D009669:Nose Neoplasms / Q000139:chemically induced / Q000473:pathology; D010212:Papilloma / Q000139:chemically induced / Q000473:pathology; D012208:Rhabdomyosarcoma / Q000139:chemically induced / Q000473:pathology; D012513:Sarcoma, Experimental / Q000139:chemically induced* / Q000473:pathology
chemical_list: D002483:Cellulose, Oxidized; D015127:9,10-Dimethyl-1,2-benzanthracene; D004121:Dimethyl Sulfoxide